主页文献库搜索
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated meta...

Capalbo(Carlo),Marchetti(Paolo),Coppa(Anna... Cancer Biol Ther 2015-02-13

...PIK3CA genes have emerged as important mechanisms of resistance to EGFR-targeted therapy in metastatic colorectal cancer...

[Endometriosis-related ovarian tumors].

Schmidt(D),Ulrich(U) Pathologe 2015-04-15

...PIK3CA and less frequently PPP2R1A and KRAS.

Activating FGFR2-RAS-BRAF mutations in ameloblastoma.

Brown(Noah A),Rolland(Delphine),McHugh(Jon... Clin Cancer Res 2015-07-01

...PIK3CA, and SMARCB1 were also identified. BRAF V600E was the most common mutation, found in 62% of ameloblastomas and in...

Inhibition of activated Ras suppresses multiple oncogenic Hub genes in human ...

Cao(Lei),Wang(Ping),Luo(Hui),Wang(Xi-Rui),... Int J Oncol 2015-06-09

...PIK3CA, MDM2, CCND1, EGFR, JUN, MYC, VEGFA, ERK1 and ERK2) but also confirmed inhibition of activated Ras reduced expres...

A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversi...

Levy(Benjamin),Spira(Alexander),Becker(Dan... J Thorac Oncol 2015-02-09

...PIK3CA mutations or PTEN loss were infrequently observed.,The addition of PX-866 to docetaxel did not improve PFS, respo...

Multiplexed molecular profiling of lung cancer using pleural effusion.

Akamatsu(Hiroaki),Koh(Yasuhiro),Kenmotsu(H... J Thorac Oncol 2015-02-09

...PIK3CA, NRAS, MEK1, AKT1, PTEN, and HER2 mutations, EGFR, MET, FGFR1, FGFR2, and PIK3CA amplifications, and ALK, ROS1, a...

The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear c...

Oishi(Tetsuro),Itamochi(Hiroaki),Kudoh(Aki... Oncol Rep 2015-02-12

...PIK3CA gene. The present study was conducted to clarify the efficacy of the inhibition of the PI3K-AKT-mTOR pathway in O...

WNT signaling and distant metastasis in colon cancer through transcriptional ...

Ormanns(Steffen),Neumann(Jens),Horst(David... Oncotarget 2015-01-23

...PIK3CA mutations or loss of PTEN expression) and nuclear β-Catenin expression, both variables were determined in 55 matc...

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in h...

Janku(Filip),Kaseb(Ahmed O),Tsimberidou(Ap... Oncotarget 2015-01-23

...PIK3CA, NF1]), Wnt pathway (n=6 [CTNNA1, CTNNB1]), MAPK pathway (n=2 [MAP2K1, NRAS]), and aberrant DNA repair mechanisms...

Panel based MALDI-TOF tumour profiling is a sensitive method for detecting mu...

Sherwood(James L),Müller(Susanne),Orr(Mari... PLoS One 2015-11-05

...PIK3CA and TP53.,The Sequenom MALDI-TOF method provides a sensitive panel-based approach which makes efficient use of pa...

上一页 159 160 161 162 163 164 165 166 167 下一页 163 / 共 353

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com